Recombinant T-cell Receptor Ligand RTL1000 Limits inflammation and Decreases Infarct Size after Experimental Ischemic Stroke in Middle-Aged Mice

We have previously demonstrated that recombinant T-cell receptor ligand 1000 (RTL1000) reduces infarct size and improves long-term functional recovery after experimental stroke in young transgenic mice expressing human leukocyte antigen DR2 (DR2-Tg). In this study, we determined the effect of RTL100...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuroscience
Main Authors: Zhu, W., Dotson, A. L., Libal, N. L., Lapato, A. S., Bodhankar, S., Offner, H., Alkayed, N. J.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4323943/
https://ncbi.nlm.nih.gov/pubmed/25556831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroscience.2014.12.037
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki